Abstract

There is growing evidence that a substantial proportion of people who complete anti-tuberculosis treatment experience significant morbidity and mortality which can negatively affect their quality of life. It is suggested that national tuberculosis programs conduct end-of-treatment assessments, but whether this is feasible is currently not known. We therefore assessed whether tuberculosis program staff could assess functional and general health status of patients at the end of treatment in five TB clinics in four provinces in China. There were 115 patients, aged 14–82 years, who completed anti-tuberculosis treatment and a post-TB assessment. There were 54 (47%) patients who continued to have symptoms, the commonest being cough, dyspnea and fatigue. Symptom continuation was significantly more common in the 22 patients with diabetes (p = 0.027) and the 12 patients previously treated for TB (p = 0.008). There were 12 (10%) current smokers, an abnormal chest X-ray was found in 106 (92%) patients and distance walked in the 6-min walking test (6MWT) ranged from 30–750 m (mean 452 ± 120); 24 (21%) patients walked less than 400 m. Time taken to perform the post-TB assessment, including the 6MWT, ranged from 8–45 min (mean 21 ± 8 min). In 98% of the completed questionnaires, health workers stated that conducting post-TB assessments was feasible and useful. This study shows that post-TB assessments can be conducted under routine programmatic conditions and that there is significant morbidity that needs to be addressed.

Highlights

  • Worldwide, tuberculosis (TB) remains a major global public health problem and one of the top 10 causes of death overall [1]

  • We have previously argued that an end-of-treatment assessment needs to be carried out within the context of a national TB program (NTP), using a simple check list that documents on going symptoms, co-morbidities, social determinants and lung function, with appropriate actions taken if disability is identified [7,8]

  • The selection of the sites was based on broad geographical coverage, sufficient numbers of TB patients registered each year and willingness of staff to attend to the post-TB work without additional resources

Read more

Summary

Introduction

Tuberculosis (TB) remains a major global public health problem and one of the top 10 causes of death overall [1]. Despite a gradual fall in TB incidence and TB mortality over the last two decades, in 2019 there were 10 million new cases of the disease and 1.4 million deaths [1]. In 2019, a group from Canada reported that longterm all-cause mortality in TB patients after they completed treatment was nearly three times higher than in a control group, with most deaths attributable to cardiovascular disease [6]. These findings indicate the need for further research to understand and address the biomedical and social factors that affect the long-term prognosis of this population

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call